TY - JOUR T1 - Prevalence of sleep apnea syndrome in morbidly obese patients JF - European Respiratory Journal JO - Eur Respir J VL - 42 IS - Suppl 57 SP - P2547 AU - Elena Ojeda Castillejo AU - Jorge García Angulo AU - Jose Miguel Rodriguez Gonzalez-Moro AU - Soledad Lopez Martin AU - Gema Sanchez Muñoz AU - Pilar De Lucas Ramos Y1 - 2013/09/01 UR - http://erj.ersjournals.com/content/42/Suppl_57/P2547.abstract N2 - Introduction: Obesity is a major risk factor for developing sleep apnea syndrome. CPAP is its treatment. Moreover, the use of CPAP may decrease perioperative complications in patients who have to undergo bariatric surgery.- Objective: To study the prevalence of OSAS in morbidly obese subjects.- Methods: We studied all patients who were referred to our unit of sleep disorders with an obesity diagnosis, using the following inclusion criteria: BMI higher than 40, acceptance of polygraphy. All patients answered a clinical questionnaire in order to assess: symptoms of sleep apnea and cardiometabolic comorbidity. Additionally, they all went through a polygraphic or polysomnographic study. The diagnosis of OSA was established with the presence of an AHI higher than 5 and the severity rating was made according to the SEPAR criteria.- Results: In three years we have studied 292 subjects with the stablished criteria, 115 men, 176 women, average age 47.1 +/-14. Average BMI 46.7. SAHS diagnosis was established in 243 cases (83.5% prevalence) of which 54 (22.2%) had mild OSA, 62 (25.5%) moderate OSA, and 127 (52.2%) severe OSA. In patients with OSA, the Epworth test average result was 7.43 +/-4.5 and in terms of comorbidity, 106 patiens had hipertension, 43.6%, 89 had dyslipidemia (36.6%) and 60 had diabetes (24.6%), 11 had had ischemic events (4.7%) and 5 had cerebrovascular disease (2%).- Conclusions: Individuals with morbid obesity have a very high prevalence of OSA in the absence of significant hypersomnolence. The need to treat these patients makes us recommend the routinary performance of polygraphic studies, even in paucisymptomatic patients. ER -